Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-24
2007-04-24
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S301000
Reexamination Certificate
active
10928674
ABSTRACT:
The invention relates to compounds represented by Formula (I):and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein each of X1–X5and R1–R5are defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula (I).
REFERENCES:
patent: 5587458 (1996-12-01), King et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5792783 (1998-08-01), Tang et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5861510 (1999-01-01), Piscopio et al.
patent: 5863949 (1999-01-01), Robinson et al.
patent: 5877305 (1999-03-01), Huston et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 6071935 (2000-06-01), Lyssikatos
patent: 6211164 (2001-04-01), Luo et al.
patent: 6383744 (2002-05-01), Green et al.
patent: 6413755 (2002-07-01), Luyten et al.
patent: 6531491 (2003-03-01), Kania et al.
patent: 6534524 (2003-03-01), Kania et al.
patent: 6995171 (2006-02-01), Autry et al.
patent: 2001/0046989 (2001-11-01), Levin et al.
patent: 606046 (1997-10-01), None
patent: 1086705 (2001-03-01), None
patent: 931788 (2002-11-01), None
patent: WO90/05719 (1990-05-01), None
patent: WO95/19970 (1995-07-01), None
patent: WO95/21613 (1995-08-01), None
patent: WO95/23141 (1995-08-01), None
patent: WO96/14843 (1996-05-01), None
patent: WO96/27583 (1996-09-01), None
patent: WO96/30347 (1996-10-01), None
patent: WO96/33172 (1996-10-01), None
patent: WO96/40142 (1996-12-01), None
patent: WO97/13760 (1997-04-01), None
patent: WO97/13771 (1997-04-01), None
patent: WO97/22596 (1997-06-01), None
patent: WO97/32856 (1997-09-01), None
patent: WO97/34876 (1997-09-01), None
patent: WO97/49688 (1997-12-01), None
patent: WO98/02434 (1998-01-01), None
patent: WO98/02437 (1998-01-01), None
patent: WO98/02438 (1998-01-01), None
patent: WO98/03516 (1998-01-01), None
patent: WO98/07697 (1998-02-01), None
patent: WO98/14451 (1998-04-01), None
patent: WO98/23613 (1998-06-01), None
patent: WO98/30566 (1998-07-01), None
patent: WO98/33768 (1998-08-01), None
patent: WO98/34915 (1998-08-01), None
patent: WO98/34918 (1998-08-01), None
patent: WO98/51344 (1998-11-01), None
patent: WO98/54093 (1998-12-01), None
patent: WO99/10349 (1999-03-01), None
patent: WO99/16755 (1999-04-01), None
patent: WO99/24440 (1999-05-01), None
patent: WO99/35132 (1999-07-01), None
patent: WO99/35146 (1999-07-01), None
patent: WO 99/46268 (1999-09-01), None
patent: WO99/52889 (1999-10-01), None
patent: WO99/52910 (1999-10-01), None
patent: WO99/61422 (1999-12-01), None
patent: WO 00/00493 (2000-01-01), None
patent: WO00/16781 (2000-03-01), None
patent: WO00/37107 (2000-06-01), None
patent: WO00/38665 (2000-07-01), None
patent: WO00/38715 (2000-07-01), None
patent: WO00/38716 (2000-07-01), None
patent: WO00/38717 (2000-07-01), None
patent: WO00/38718 (2000-07-01), None
patent: WO00/38719 (2000-07-01), None
patent: WO00/38730 (2000-07-01), None
patent: WO00/38786 (2000-07-01), None
patent: WO01/16306 (2001-03-01), None
patent: WO01/21771 (2001-03-01), None
patent: WO01/70268 (2001-09-01), None
patent: WO01/74296 (2001-10-01), None
patent: WO01/74360 (2001-10-01), None
patent: WO01/85796 (2001-11-01), None
patent: WO02/30453 (2002-04-01), None
patent: WO02/41882 (2002-05-01), None
patent: WO02/064170 (2002-08-01), None
patent: WO02/070494 (2002-09-01), None
patent: WO03/006059 (2003-01-01), None
patent: WO 03/009852 (2003-02-01), None
patent: WO03/035047 (2003-05-01), None
Parikh et al., Expression and Regulation of the Novel Vascular Endothelial Growth Factor Receptor Neuropilin-1 by Epidermal Growth Factor in Human Pancreatic Carcinoma, Cancer, 98(4):720-729 (2003).
Sumitomo et al., Immunohistochemical study of fibroblast Growth Factor-2 (FGF-2) and Fibroblast Growth Factor Receptor (FGF-R) in experimental squamous Cell Carcinoma of Rat Submandibular Gland, Oral Oncology 35:98-104 (1999).
Zhu & Witte, Inhibition of Tumor Growth and Metastasis by Targeting Tumor-Associated Angiogenesis with Antagonists to the Receptors of Vascular Endothelial Growth Factor, Investigational New Drugs, 17:195-212 (1999).
He Mingying
Kania Robert Steven
Lou Jihong
Agouron Pharmaceuticals , Inc.
Balls R. James
Chang Celia
Pugmire Matthew J.
Zielinski Bryan C.
LandOfFree
Thienopyridine-phenylacetamides and their derivatives useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thienopyridine-phenylacetamides and their derivatives useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thienopyridine-phenylacetamides and their derivatives useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760717